NSEUpdates7 Aug 2026 · 7 Aug 2026, 06:11 pm

Updates

Quick Heal Technologies Limited · QUICKHEAL

✦ AI SummaryResults

Quick Heal Technologies Limited has informed the Exchange regarding 'Machine Readable Financial Results' for the quarter ended June 30, 2026. The company has approved unaudited consolidated and standalone financial results, issued a Limited Review Report with an unmodified opinion, and proposed the re-appointment of Mr. Richard Stiennon as Non-Executive Independent Director.

Analysis Scores

Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Quick Heal Technologies Limited has informed the Exchange regarding 'Machine Readable Financial Results'.

Attachments (1)

📄

QUICKHEAL_07082026181140_MRF_Financials.pdf

pdf

Download →
View document text
Ref. No.: QHTL/Sec/SE/2026-27/21 July 30, 2026 To, To, The Manager, The Manager, Corporate Services, Corporate Services, BSE Limited, National Stock Exchange of India Limited, 14th Floor, P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Security ID: QUICKHEAL Symbol: QUICKHEAL Security Code: 539678 Series: EQ Subject: Outcome of Board Meeting held on July 30, 2026. Dear Sir / Madam, Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its meeting held on July 30, 2026, which commenced at 05:30 PM IST and concluded at 8:30 PM IST, has approved following: 1. Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended June 30, 2026. 2. M S K A & Associates LLP, Chartered Accountants, Statutory Auditors of the Company, have issued a Limited Review Report with an unmodified opinion on the above-mentioned results. 3. Based on the recommenda(cid:415)on of Nomina(cid:415)on and Remunera(cid:415)on Commi(cid:425)ee, the Board considered and proposed the re-appointment of Mr. Richard S(cid:415)ennon (DIN: 09324046) as Non-Execu(cid:415)ve Independent Director of the Company for a second term of 5 consecu(cid:415)ve years w.e.f. September 27, 2026, for approval of the shareholders at the ensuing Annual General Mee(cid:415)ng. The details are enclosed as Annexure A. 4. Shifting of the Registered Office of the Company within the same city limit from Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune – 411014 to S. No. 1442-1445, Thube Park, Shivajinagar, Pune – 411005, with effect from July, 30, 2026 5. Books of Accounts are kept at the Corporate Office situated at 3rd and 4th Floor, Indiqube Orchid, Shastrinagar, Yerwada, Pune - 411006 with effect from July, 30, 2026. A copy of the Press Release and Investor Presentation in respect of the aforesaid Financial Results are enclosed herewith. This is for your information and records. For Quick Heal Technologies Limited Vikram Dhanani Compliance Officer ANNEXURE A Sr. No. Details of Event that needs to be provided Information of such events 1 Name of the Director / KMP / Senior Mr. Richard Stiennon Management 2 Reason for change viz appointment, Re-appointment as Non-Executive reappointment, resignation, removal, death Independent Director, subject to or otherwise approval of the shareholders at the ensuing Annual General Meeting. 3 Date of appointment / reappointment / Re-appointment for a second term of 5 cessation (as applicable) & term of consecutive years with effect from appointment/ re-appointment) September 27, 2026, to September 26, 2031. 4 Brief Profile (in case of appointment) Mr. Richard Stiennon has over 30 years of rich experience across the industry, Mr. Richard Stiennon is one of the most renowned analysts and thought leaders in the global cybersecurity industry. During his career, he had advised the executive teams and boards at some of the biggest cybersecurity companies, including Symantec, McAfee, Cisco, Microsoft and Trend Micro. In his previous stints, he has held senior leadership positions at Gartner, PwC, Webroot Software, Fortinet, and Blancco Technology Group. He was an advisor on the Extreme Cyber Advisory Panel for Commonwealth Bank in Australia. Additionally, he had provided due diligence for several M&A deals including the acquisition of Trustwave by Singtel. 5 Disclosure of relationships between Mr. Richard Stiennon is not related to directors (in case of appointment of a any Director of the Company. director) 6 Information as required under BSE circular Mr. Richard Stiennon is not debarred Number LIST/COM/14/2018-19 and NSE from accessing the capital markets circular no. NSE/CML/2018/24 dated 20th and/or restrained from holding the June, 2018 position of Director in any listed Company by virtue of any order of the Securities and Exchange Board of India or any other such authority. 7 Letter of resignation along with detailed Not Applicable reason for resignation 8 Names of listed entities in which the Not Applicable resigning Independent Director holds directorships, indicating the category of directorship and membership of board committees, if any. 9 The independent director shall, along with Not Applicable the detailed reasons, also provide a confirmation that there is no other material reasons other than those provided. 10 Confirmation in compliance with SEBI Letter Mr. Richard Stiennon is not debarred dated June 14, 2018 read along with from holding office by virtue of SEBI Exchange Circular dated June 20, 2018 Order. (Affirmation that the person proposed to be appointed as Director is not debarred from holding the office by virtue of any SEBI Order or any other authority) A. Quarterly Financial Results QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pone• 411014 CIN: L72200MH1995PLC091408 STATEMENT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNObOGIES LIMITED AND ITS SUBSIDIARIES FOR THE QUARTER ENDED JUNE 30, 2026 (f in Crores, except earnine:s per share) Quarter ended Year ended Sr. No. Particulars June 30, 2026 March 31, 2026 ·June 30, 2025 March 31, 2026 Unaudited (refer note 1) Unaudited (Audited) I Income Revenue from operations 44.99 48.73 57.23 261.02 Other income 14.10 3.75 5.75 22.83 Total income 59.09 52.48 62.98 283.85 2 Expenses Cost of material consumed 0 49 0.14 0.86 4 57 Purchase of security software products 0.01 0 08 0 08 Changes in inventory of security software products 0 14 0.17 (0.06) (0.37) Employee benefits expense 43 20 45.89 43,89 182.90 Finance costs . 0.03 0,06 020 Depreciation and amortisation expense 3 85 4.07 2,96 13.90 Other expenses 18 72 31 77 22.27 103.21 Total expenses 66.41 82.15 69.98 304.49 3 Profit/ (loss) before tax (1-2) (7.32) (29.67) (7.00) (20.64) 4 Tax expense Current tax 0,13 0.05 0.18 Adjustments of tax relating to earlier periods (Net) . . . . Deferred tax benefit (2.17) (9.78) (1 49) (9.89) Total tax expense/ (benefit) (2.04) (9.73) (1.49) (9.71) 5 Profit/ (loss) after tax (3-4) (5.28) (19.94) (5.51) (10.93) 6 Other comprehensive income/ (loss) (net of tax) Items that will not be reclassified subsequently to profit or loss: Gain/ (loss) on re-measurement of defined benefit plans 0.04 0 62 0 30 1.10 Income tax effect (0.01) (0.16) (0.08) (0 28) 0.03 0.46 0.22 0.82 Net (loss) or gain on FVOCI instruments 0,20 0.21 Income tax effect . (0.03) . (0.03) - 0.17 . 0.18 Items that will be reclassified subsequently to profit or loss : Exchange differences on translation of foreign operations 0.23 . 0.09 0.14 Total other comprehensive income/ (loss) for the period 0.26 0.63 0.31 1.14 7 Total comprehensive income/ (loss) (after tax) (5+6) (5.02) (19.31) (5.20) (9.79) 8 Paid-up equity share capital (face value oft 10 each, fully paid up) 54.25 54.24 54.02 54 24 9 Other equity excluding revaluation reserves as per balance sheet 11-<..0chno~ ~ . . - 382 28 10 Earnings/ (loss) per share oft JO each: );I ,:Eune (not annualised except for the year ended March) ;t) a) Basic •;,. (0.94) (3 58) (1.00) (1 98) b) Diluted ~o*?*' (0.94) (3.58) (1.00) (1.98) QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune -411014 CIN: L72200MH1995PLC091408 NOTES TO THE STATEMENT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED AND ITS SUBSIDIARIES FOR THE QUARTER ENDED JUNE JO, 2026 Notes lo financial rtsults: I The, unaudited consolidated financial results have bct.n prepared 1n .scecinianu wnh Indian Accounting Standards (Ind AS) notified under Sec-tion Ill or the Companies Act, 2013 read with tht Companies (Indian Accounting S1&ndntd Rules}, 2015 (:as-amend [Showing first 8,000 characters — download PDF for full document]